The Waiting Time for Inter-Country Spread of Pandemic Influenza

被引:38
作者
Caley, Peter [1 ]
Becker, Niels G. [1 ]
Philp, David J. [1 ]
机构
[1] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia
来源
PLOS ONE | 2007年 / 2卷 / 01期
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
D O I
10.1371/journal.pone.0000143
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background. The time delay between the start of an influenza pandemic and its subsequent initiation in other countries is highly relevant to preparedness planning. We quantify the distribution of this random time in terms of the separate components of this delay, and assess how the delay may be extended by non-pharmaceutical interventions. Methods and Findings. The model constructed for this time delay accounts for: (i) epidemic growth in the source region, (ii) the delay until an infected individual from the source region seeks to travel to an at-risk country, (iii) the chance that infected travelers are detected by screening at exit and entry borders, (iv) the possibility of in-flight transmission, (v) the chance that an infected arrival might not initiate an epidemic, and (vi) the delay until infection in the at-risk country gathers momentum. Efforts that reduce the disease reproduction number in the source region below two and severe travel restrictions are most effective for delaying a local epidemic, and under favourable circumstances, could add several months to the delay. On the other hand, the model predicts that border screening for symptomatic infection, wearing a protective mask during travel, promoting early presentation of cases arising among arriving passengers and moderate reduction in travel volumes increase the delay only by a matter of days or weeks. Elevated in-flight transmission reduces the delay only minimally. Conclusions. The delay until an epidemic of pandemic strain influenza is imported into an at-risk country is largely determined by the course of the epidemic in the source region and the number of travelers attempting to enter the at-risk country, and is little affected by non-pharmaceutical interventions targeting these travelers. Short of preventing international travel altogether, eradicating a nascent pandemic in the source region appears to be the only reliable method of preventing country-to-country spread of a pandemic strain of influenza.
引用
收藏
页数:8
相关论文
共 19 条
  • [1] Becker N.G., 1989, Analysis of Infectious Disease Data
  • [2] Caswell H., 2000, Matrix population models, V1
  • [3] Delaying the international spread of pandemic influenza
    Cooper, Ben S.
    Pitman, Richard J.
    Edmunds, W. John
    Gay, Nigel J.
    [J]. PLOS MEDICINE, 2006, 3 (06) : 845 - 855
  • [4] Strategies for mitigating an influenza pandemic
    Ferguson, Neil M.
    Cummings, Derek A. T.
    Fraser, Christophe
    Cajka, James C.
    Cooley, Philip C.
    Burke, Donald S.
    [J]. NATURE, 2006, 442 (7101) : 448 - 452
  • [5] Strategies for containing an emerging influenza pandemic in Southeast Asia
    Ferguson, NM
    Cummings, DAT
    Cauchemez, S
    Fraser, C
    Riley, S
    Meeyai, A
    Iamsirithaworn, S
    Burke, DS
    [J]. NATURE, 2005, 437 (7056) : 209 - 214
  • [6] Mitigation strategies for pandemic influenza in the United States
    Germann, TC
    Kadau, K
    Longini, IM
    Macken, CA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (15) : 5935 - 5940
  • [7] Harris TE, 1963, Die Grundlehren der mathematischen Wissenschaften, V119
  • [8] Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza - Randomized controlled trials for prevention and treatment
    Hayden, FG
    Treanor, JJ
    Fritz, RS
    Lobo, M
    Betts, RF
    Miller, M
    Kinnersley, N
    Mills, RG
    Ward, P
    Straus, SE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (13): : 1240 - 1246
  • [9] Will travel restrictions control the international spread of pandemic influenza?
    Hollingsworth, TD
    Ferguson, NM
    Anderson, RM
    [J]. NATURE MEDICINE, 2006, 12 (05) : 497 - 499
  • [10] Border screening for SARS
    John, RKS
    King, A
    de Jong, D
    Bodie-Collins, M
    Squires, SG
    Tam, TWS
    [J]. EMERGING INFECTIOUS DISEASES, 2005, 11 (01) : 6 - 10